Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BBLNNASDAQ:BTTXNASDAQ:PIIINASDAQ:VSEE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLNBabylon$0.55$0.60$0.46▼$28.50$14.10M2.42415,159 shsN/ABTTXBetter Therapeutics$0.00$0.00$0.00▼$0.03$5K1.1918,713 shs15,429 shsPIIIP3 Health Partners$6.47-0.5%$8.33$6.47▼$33.73$46.72M0.8420,349 shs3,519 shsVSEEVsee Health$1.13+3.6%$1.16$1.00▼$14.47$4.07MN/A1.03 million shs24,347 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLNBabylon0.00%0.00%0.00%0.00%0.00%BTTXBetter Therapeutics0.00%0.00%-50.00%-50.00%-98.95%PIIIP3 Health Partners-0.46%-12.50%-26.31%-30.09%-77.76%VSEEVsee Health+3.64%-4.00%-3.77%-10.34%+112,969,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBLNBabylonN/AN/AN/AN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/APIIIP3 Health Partners1.2592 of 5 stars3.32.00.00.00.00.80.6VSEEVsee Health0.9056 of 5 stars2.03.00.00.00.60.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLNBabylon 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/APIIIP3 Health Partners 2.50Moderate Buy$16.25151.16% UpsideVSEEVsee Health 4.00Strong Buy$5.00342.60% UpsideCurrent Analyst Ratings BreakdownLatest BBLN, PIII, VSEE, and BTTX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025PIIIP3 Health PartnersLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$50.00 ➝ $20.00(Data available from 6/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLNBabylon$1.15B0.01N/AN/A($10.29) per share-0.05BTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/APIIIP3 Health Partners$1.49B0.03$2.79 per share2.32$0.45 per share14.38VSEEVsee Health$6.38M0.64N/AN/A($3.40) per share-0.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLNBabylon-$221.45M-$23.03N/A∞N/A-35.54%N/A-105.06%N/ABTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)PIIIP3 Health Partners-$57.77M-$47.28N/AN/AN/A-6.95%-71.31%-11.93%8/6/2025 (Estimated)VSEEVsee Health-$4.41MN/A0.00∞N/AN/A-182.59%-58.26%6/12/2025 (Estimated)Latest BBLN, PIII, VSEE, and BTTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025N/AVSEEVsee Health-$0.09-$0.12-$0.03N/A$3.52 million$3.90 million5/15/2025Q1 2025PIIIP3 Health Partners-$5.00-$6.28-$1.28-$6.28$362.09 million$373.23 million3/27/2025Q4 2024PIIIP3 Health Partners-$8.50-$16.00-$7.50-$0.36$378.88 million$370.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBLNBabylonN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/APIIIP3 Health PartnersN/AN/AN/AN/AN/AVSEEVsee HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLNBabylonN/A1.071.07BTTXBetter TherapeuticsN/AN/AN/APIIIP3 Health Partners1.110.530.53VSEEVsee Health0.160.370.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLNBabylon37.90%BTTXBetter Therapeutics34.00%PIIIP3 Health Partners7.75%VSEEVsee Health1.01%Insider OwnershipCompanyInsider OwnershipBBLNBabylon38.52%BTTXBetter Therapeutics51.40%PIIIP3 Health Partners17.79%VSEEVsee Health6.59%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLNBabylon1,89525.61 million15.75 millionNot OptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionablePIIIP3 Health Partners5007.19 million294.74 millionNot OptionableVSEEVsee HealthN/A3.60 million3.37 millionN/ABBLN, PIII, VSEE, and BTTX HeadlinesRecent News About These CompaniesVSee Health faces Nasdaq compliance issue over late filingsJune 1, 2025 | investing.comVSee Health faces Nasdaq delisting over late filingJune 1, 2025 | uk.investing.comVSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q FilingMay 30, 2025 | businesswire.comVSee Health launches telehealth initiative in the PhilippinesMay 17, 2025 | investing.comVSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote PhilippinesMay 16, 2025 | businesswire.comVSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K FilingMay 12, 2025 | businesswire.comVSee Health Inc. Faces Nasdaq Delisting Over Late FilingMay 10, 2025 | investing.comVSee Health unveils AI-driven telenursing platformApril 18, 2025 | uk.investing.comVSee Unveils Advanced Telenursing Robotics Solution Targeting 3-5% Reduction in Hospital Nursing CostsApril 16, 2025 | finance.yahoo.comVSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare Market Featured Image featured image Admin MessageApril 2, 2025 | markets.businessinsider.comVSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare MarketApril 2, 2025 | prnewswire.comVSee Health issues letter to shareholders updating progressMarch 7, 2025 | markets.businessinsider.comVSee Issues Shareholder Letter Highlighting 2024 Achievements and Strong Growth Outlook for 2025March 6, 2025 | finance.yahoo.comVSee Health wins telehealth contract for mental health servicesMarch 6, 2025 | finance.yahoo.comVSee Health Secures $444K County Government Contract, Expanding Market Reach in Public Sector HealthcareMarch 5, 2025 | finance.yahoo.comVSee Health and LanguageLine Team Up to Boost Telehealth Adoption with Seamless, Scalable Multilingual CareFebruary 25, 2025 | finance.yahoo.comVSee Health and LanguageLine Team Up to Boost Telehealth Adoption with Seamless, Scalable Multilingual CareFebruary 25, 2025 | businesswire.comMaxim Group Initiates Coverage of VSee Health (VSEE) with Buy RecommendationFebruary 25, 2025 | msn.comVSee Health initiated with a Buy at MaximFebruary 24, 2025 | markets.businessinsider.comMaxim starts VSee Health at Buy, sees good momentum in new contractsFebruary 24, 2025 | markets.businessinsider.comMedia Sentiment Over TimeBBLN, PIII, VSEE, and BTTX Company DescriptionsBabylon NYSE:BBLNBabylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services. Babylon Holdings Limited was founded in 2013 and is headquartered in Austin, Texas.Better Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 06/5/2025 11:23 AM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.P3 Health Partners NASDAQ:PIII$6.47 -0.03 (-0.46%) Closing price 06/5/2025 03:54 PM EasternExtended Trading$6.28 -0.19 (-2.86%) As of 06/5/2025 06:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Vsee Health NASDAQ:VSEE$1.13 +0.04 (+3.64%) Closing price 06/5/2025 03:59 PM EasternExtended Trading$1.10 -0.02 (-2.19%) As of 06/5/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Is Meta Plotting a Stablecoin Comeback Years After Libra's Flop? NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise Robinhood Stock Keeps Giving Investors Reasons To Buy Hims & Hers Stock: Buy the Dip or Wait It Out? Boeing: Analyst Upgrades & Order Boom Signal Clearer Skies CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast A New All-Time High Is Coming Soon for Credo Technology Group Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
